期刊文献+

重组杆状病毒载体在哺乳动物细胞中的表达 被引量:2

In vitro gene transfer into mammalian cells by recombinant baculovirus vector
下载PDF
导出
摘要 目的 探讨重组杆状病毒作为哺乳动物基因转导载体的可行性及其转导特点。方法 应用Bac-to-Bac杆状病毒表达系统制备重组杆状病毒Bac-GFP,以不同MOI的病毒和不同终浓度丁酸钠感染各哺乳动物细胞系。通过荧光倒置相差显微镜和流式细胞仪观察检测细胞转导率和绿色荧光蛋白(GFP)表达强度。结果 发现HEK293细胞中,Bac-GFP转导率和GFP表达强度随着MOI和丁酸钠浓度的提高而显著增高(P<0.01),报告基因GFP的表达第2d最高,至少可持续9d。Bac-GFP可感染不同种属不同组织的哺乳动物细胞系,但转导率有差异。结论 重组杆状病毒可以用于体外基因转导。 Objective To study the feasibility and the characteristics of recombinant baculovirus as mammalian gene transfer vector. Methods After the generation of recombinant baculovirus Bac-GFP according to Bac-to-Bac baculovirus expression system, mammalian cell lines were infected by Bac-GFP with different multiplicities of infection (MOI) and different concentrations of sodium butyrate. The transduced cell rate and mean fluorescence strength (MFS) were detected by fluorescence microscopy and flow cytometry. Results In HEK293 cell line, the transduced cell rate and MFS significantly increased with increasing MOI and concentration of sodium butyrate ( P < 0.01). Expression of the reporter gene GFP reached the highest level on the second day postinfection. Mammalian cell lines from different genus and different tissues can be infected by Bac-GFP, but their transduced cell rate is extremely different. Conclusion Recombinant baculovirus can be a useful vector for in vitro gene transfer.
出处 《上海第二医科大学学报》 CSCD 2004年第10期806-809,832,共5页 Acta Universitatis Medicinalis Secondae Shanghai
基金 上海市科学技术发展基金(014119093)资助项目
关键词 表达 重组杆状病毒 基因转导 丁酸钠 哺乳动物细胞 感染 钠浓度 绿色荧光蛋白(GFP) 报告基因 载体 baculovirus gene transduction green fluorescent protein butyrate
  • 相关文献

参考文献11

  • 1Condreay JP, Witherspoon SM, Clay WC, et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector [ J ]. Proc Natl Acad Sci USA, 1999,96(1): 127-132.
  • 2Duisit G, Saleun S, Douthe S, et al. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient transfer in mammalian cells[J]. J Gene Med, 1999,1(2): 93 -102.
  • 3Boyce FM, Bucher NR. Baculovirus-mediated gene transfer into mammalian cells [ J]. Proc Natl Acad Sci USA, 1996,93 (6):2348 -2 352.
  • 4Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene-delivery vector [ J ]. Trends Biotechnol, 2002,20 ( 4 ): 173 - 180.
  • 5Hofmann C, Sandig V, Jennings G, et al. Efficient gene transfer into human hepatocytes by baculovirus vector[ J]. Proc Natl Acad Sci USA, 1995, 92(22): 10 099 -10 103.
  • 6Palombo F, Monciotti A, Recchia A, et al. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adenoassociated virus vector[ J]. J Virol, 1998,72(6): 5 025 -5 034.
  • 7Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouseskeletal muscle mediated by baculovirus vectors [ J ]. Hum Gene Ther, 2001,12(8): 871 -881.
  • 8Sarkis C, Serguera C, Petres S, et al. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector[ J]. Proc Natl Acad Sci USA, 2000,97(26): 14 638 -14 643.
  • 9Airenne K J, Hiltunen MO, Turunen MP, et al. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery[ J]. Gene Ther, 2000,7(17): 1 499-1 504.
  • 10Sandig V, Hofmann C, Steinert S, et al. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors [ J]. Hum Gene Ther, 1996,7(16): 1 937 -1 945.

共引文献1

同被引文献18

  • 1Yu-chenHU.Baculovirus as a highly efficient expression vector in insect and mammalian cells[J].Acta Pharmacologica Sinica,2005,26(4):405-416. 被引量:36
  • 2Pels K, Labinaz M, O'Brien ER. Arterial wall neovascularization: potential role in atherosclerosis and restenosis[J]. Jpn Circ J, 1997,61(11): 893-904.
  • 3Kwon HM, Sangiorgi G, Ritman EL, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia [J]. J Clin Invest, 1998,101(8): 1551-1556.
  • 4Thomas JP, Arzoomanian RZ, Alberti D, et al. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors [J]. J Clin Oncol, 2003,21(2): 223-231.
  • 5Eder JP Jr, Supko JG, Clark JW, et al. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily[J]. J Clin Oncol, 2002,20(18): 3772-3784.
  • 6Hendel RC, Henry TD, Rocha-Singh K, et al. Effect of intracoronary recombinant Human vascular endothelial growth factor on myocardial perfusion. Evidence for a dose-dependent effect [J]. Circulation, 2000,101(18): 118-121.
  • 7O'Brien ER, Garvin MR, Dev R, et al. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol, 1994,145(4): 883-894.
  • 8Zhang Y, Cliff WJ, Schoefl GI, et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis [J]. Am J Pathol, 1993,143(1): 164-172.
  • 9O'Brien KD, McDonald TO, Chait A, et al. Neovascular expression of E-selectin, ICAM-1, and VCAM-1 in human atherosclerosis and their relation to intimal leukocyte content [J]. Circulation, 1996,93(4): 672-682.
  • 10Ignatescu MC, Gharehbaghi-Schnell E, Hassan A, et al. Expression of the angiogenic protein, platelet-derived endothelial cell growth factor, in coronary atherosclerotic plaques: in vivo correlation of lesional microvessel density and constrictive vascular remodeling [J]. Arterioscler Thromb Vasc Biol, 1999,19(10): 2340-2347.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部